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Radiation risk of screening with
low dose CT
I read with interest the article by
MacRedmond et al1 on screening for lung
cancer using low dose CT scanning and the
related editorial by Gleeson2 which provides a
comprehensive summary of the benefits and
potential pitfalls of such a screening.
However, I noticed that, in both articles, the
important issue of the potential radiation
risks associated with low dose CT screening
for lung cancer has not been addressed.
Previously published reports have sug-
gested radiation risks even with a low dose
CT scan as part of a regular screening
programme3 and also of a possible synergistic
interaction between the risk from smoking
and radiation exposure.4–7 Brenner3 estimates
that, if 50% of all current and former smokers
in the US population aged 50–75 years
received annual CT screening, the estimated
number of lung cancers associated with
radiation from screening would be 1.8%
(95% credibility interval 0.5% to 5.5%) more
than the otherwise expected number.
Considering an upper limit of a 5.5% increase
in lung cancer risk attributable to annual CT
related radiation exposure, he feels that a
mortality benefit of considerably more than
5% would be necessary to outweigh the
potential risks of radiation. This estimation
was derived from cancer incidence data for
atomic bomb survivors.7
Several other reports4–6 8 have suggested a
link between radiation exposure and lung
cancer. Potential radiation risks associated
with multiple CT scans should therefore be
considered as one of the limiting factors for
such screening.
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Effect of dichotomising age in
multivariate model analysis
We read with interest the paper by Soler-
Catalun˜a and colleagues1 that examined—in
an impressive prospective study with 5 years
follow up—factors predicting poor prognosis
and mortality in patients with severe acute
exacerbations of chronic obstructive pulmon-
ary disease (AECOPD). Their findings are
complementary with the current available
literature in identifying that older age,
arterial carbon dioxide tension, and acute
exacerbations were independent predictors of
mortality in their cohort group.
We have concerns, however, regarding
both their analyses and conclusions. Firstly,
several studies2–4 have given advice on the
limitations of dichotomising continuous pre-
dictors as they come at a cost ‘‘as explanatory
variables could be seriously misleading, both
in respect of which variables are significant in
the model, and perhaps also with respect to
the overall predictive ability’’.2 Soler-
Catalun˜a and colleagues state that in their
multivariate model ‘‘the frequency of acute
exacerbations, age and Charlson index were
analysed as categorical variables’’.1
Secondly, and perhaps more importantly,
the authors have reported older age (clearly a
non-modifiable factor) as a predictor of
death. They do not state whether they believe
this to be old age per se or an age related
potentially modifiable variable. Have the
authors collected data on social support,
physical disability, depression, quality of life,
and any palliative care their patients may
have received during the follow up period?
These variables may have some effect on
mortality in this exclusively male COPD
patient cohort. Our own group has recently
published data on 1 year mortality following
hospitalisation for AECOPD in a slightly older
group of subjects (mean age 73 years v
71 years in the patients studied by Soler-
Catalun˜a and colleagues) with worse baseline
spirometry (mean percentage predicted FEV1
39%). In our study age was not a mortality
predictor on either univariate or multivariate
analysis. Quality of life, level of disability,
severity of depression, readmission, use of
long term oxygen therapy, and duration of
original admission (all of which are arguably
related to age) were all univariate predictors
of 12 month mortality, with only the quality
of life score remaining a significant predictor
on multivariate analysis.
We wonder whether the inclusion of age
related variables in the study by Soler-
Catalun˜a et al, together with the use of age
as a continuous variable, might have resulted
in qualitatively or quantitatively different
conclusions regarding the effect of age on
prognosis. However, the inclusion of duration
of original admission and of frequency of
readmission in our own list of predictors5
would support their suggestion that severe
AECOPD could have an adverse impact on
longer term mortality.
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Authors’ reply
We wish to thank Dr Yohannes for his
interest and comments on our study1 and
have the following comments on the ques-
tions he raises.
Firstly, although it is true that in some
cases the transformation of continuous vari-
ables into dichotomised variables my induce
some changes in the results obtained, in
other cases the use of continuous data may
conceal some partial effect, particularly if the
predictive relation is non-linear. In fact, in
our study the only age group to show a poorer
prognosis were those aged >75 years (odds
ratio (OR) 5.26, 95% CI 2.70 to 10.24). In the
same way, categorisation of the number of
exacerbations allowed us to review the
differential effect of repeated exacerbations.
For these reasons, and in order to make
interpretation of the results easier, we
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decided to apply categorisation of some
continuous variables in our study. On the
other hand, we should mention that
this transformation of variables did not
modify the results, as both age and the
number of exacerbations behaved as inde-
pendent prognostic factors on inclusion in
the model as continuous variables.
Specifically, in this predictive equation, age
proved to be an independent prognostic
variable with an OR of 1.06 (95% CI 1.01 to
1.11). The same applies to the number of
exacerbations with an OR of 1.20 (95% CI
1.03 to 1.39).
Secondly, with regard to the role of age as a
predictor of mortality, different studies invol-
ving both stable patients2 and acute cases3 4
have also found age to be an adverse
prognostic factor. Despite such evidence, we
consider the hypothesis suggested by
Yohannes—that other age related and poten-
tially modifiable variables would determine
the prognostic effect attributed to age—to be
very interesting. Unfortunately, in our analy-
sis we did not include measures such as social
support, physical disability, depression, or
quality of life so we are unable to assess their
specific weight. Almagro et al,5 in a study that
also explored mortality predictors after hos-
pitalisation and which considered variables of
this kind, found age to have a predictive
value in the univariate analysis, but this
effect disappeared in the multivariate study.
Therefore, as suggested by Yohannes, it is
probable that the effect of age may be
minimised when other predictors that condi-
tion or define such an effect are included in
the model.
In conclusion, age dichotomisation did not
substantially change the results and conclu-
sions drawn in our study. Re-analysis of the
data using continuous (non-dichotomised)
variables continues to suggest that severe
exacerbations are independent predictors of
mortality.
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Diaphragm paralysis after
nephrectomy
We read with interest the case report by Moore
et al1 on the diaphragm weakness of two
patients after anatomically distant surgery.
We are currently following a patient who
had bilateral paralysis of the diaphragm after a
nephrectomy for renal cancer. The patient, a
60 year old male non-smoker without any
concomitant cardiac or lung disease, under-
went surgery in August 2004 and immediately
after the operation he complained of orthop-
noea. Chest radiographs showed the elevation
of both hemidiaphragms, which was not
present preoperatively, along with a restrictive
ventilatory defect detected by spirometry (TLC
61% predicted, VC 72% predicted, FEV1 67%
predicted, FEV1/VC 70%). The diagnosis of
bilateral paralysis was confirmed by electro-
myography and respiratory muscle strength
assessment in October 2004. Because of a
nocturnal oxygen desaturation, he started
with nightly non-invasive ventilation. Up to
now he has also undergone periodic courses of
respiratory muscle training. In 2004 and 2005
he was checked regularly and an improvement
in VC was found, but not in PImax nor in
TwPdi. Moreover, at the December 2005 check
up the nocturnal oxygen desaturation had
significantly improved and the patient had
stopped the ventilation support.
Diaphragm paralysis is associated with renal
cancer and is considered to be a paraneoplastic
syndrome.2 3 In our patient, however, the
temporal link between the surgical operation
and paralysis is evident. Moreover, during the
operation and after the perioperative period
our patient did not undergo central venous
cannulation, nor did he experience any elec-
trolyte disturbance. Postoperatively, the
patient also underwent magnetic resonance
imaging which excluded any injury to his
spinal cord. The similarity between the case
histories presented by Moore et al1 and our
patient therefore appears to be evident.
In addition, we think the patient’s follow
up is of interest. So far, the patient’s VC
has recovered 0.48 l, being 4.2 l and 86%
of predicted value in orthostatism. Further-
more, VC now accounts for 2.3 l and 47% of
predicted in clinostatism and can assure a
normal oxygen saturation during sleep.
However, the patient’s diaphragm is still
paralysed, since the TwPdi value is extremely
low (3 cm H2O) and the fall in VC from
orthostatism to clinostatism is significant
(45%). The recovery in VC might be due only
to the increase in strength of the accessory
inspiratory muscles, probably due to the
respiratory muscle training courses. This
finding further supports the recommendation
by Moore et al1 to measure the diaphragm
strength separately from global inspiratory
muscle strength in patients with raised
hemidiaphragms after surgery.
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